NLRP3 inflammasome activation and IL-1β secretion is upregulated in GC, induce epithelial cells proliferation and tumorigenesis by binding to cyclin-D1 promoter which could be reversed by miRNA-22. The gene discussed is IL1B; the disease is gastric cancer.